Atara Biotherapeutics (ATRA) Insider Trading & Ownership $7.79 -0.14 (-1.77%) (As of 09/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Atara Biotherapeutics (NASDAQ:ATRA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.70%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$64,380.00Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$175,833.27 Get ATRA Insider Trade Alerts Want to know when executives and insiders are buying or selling Atara Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ATRA Insider Buying and Selling by Quarter Ad Porter & CompanyWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. Atara Biotherapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/16/2024Anhco NguyenEVPSell1,821$6.63$12,073.23 8/16/2024Eric J HyllengrenCFOSell1,070$6.63$7,094.10 8/16/2024Pascal TouchonCEOSell3,038$6.63$20,141.94 5/16/2024Anhco NguyenEVPSell1,715$15.50$26,582.50 5/16/2024Eric J HyllengrenCFOSell1,145$15.50$17,747.50 5/16/2024Pascal TouchonCEOSell3,260$15.50$50,530.00 The $15 "Insider Secret" That Could Save Your Retirement (Ad)What if I told you there's a $15 stock that a billionaire insider just poured $47 MILLION into? That's right. You can grab shares of this potential retirement-maker for less than you'd pay for lunch.Click here to discover the name and ticker of this "$15 billionaire-backed retirement stock" >>>3/4/2024Anhco NguyenEVPSell429$18.00$7,722.00 3/4/2024Pascal TouchonCEOSell993$18.00$17,874.00 11/16/2023Anhco NguyenEVPSell354$9.75$3,451.50 11/16/2023Eric J HyllengrenCFOSell478$9.75$4,660.50 11/16/2023Pascal TouchonCEOSell816$9.75$7,956.00 11/13/2023Carol Giltner GallagherDirectorBuy7,160$5.50$39,380.00 11/10/2023William K HeidenDirectorBuy4,000$6.25$25,000.00 (Data available from 1/1/2013 forward) ATRA Insider Trading Activity - Frequently Asked Questions Who is on Atara Biotherapeutics's Insider Roster? The list of insiders at Atara Biotherapeutics includes Amar Murugan, Anhco Nguyen, Carol Giltner Gallagher, Eric J Hyllengren, Jakob Dupont, Joe Newell, Matthew K Fust, Pascal Touchon, Utpal Koppikar, and William K Heiden. Learn more on insiders at ATRA. What percentage of Atara Biotherapeutics stock is owned by insiders? 3.70% of Atara Biotherapeutics stock is owned by insiders. Learn more on ATRA's insider holdings. Which Atara Biotherapeutics insiders have been buying company stock? The following insiders have purchased ATRA shares in the last 24 months: Carol Giltner Gallagher ($39,380.00), and William K Heiden ($25,000.00). How much insider buying is happening at Atara Biotherapeutics? Insiders have purchased a total of 11,160 ATRA shares in the last 24 months for a total of $64,380.00 bought. Which Atara Biotherapeutics insiders have been selling company stock? The following insiders have sold ATRA shares in the last 24 months: Amar Murugan ($62,767.50), Anhco Nguyen ($49,829.23), Eric J Hyllengren ($59,106.85), Jakob Dupont ($37,750.75), Pascal Touchon ($358,457.94), and Utpal Koppikar ($66,441.50). How much insider selling is happening at Atara Biotherapeutics? Insiders have sold a total of 21,994 Atara Biotherapeutics shares in the last 24 months for a total of $634,353.77 sold. More Insider Trading Tools from MarketBeat Related Companies: Cortexyme Insider Transactions AlloVir Insider Transactions BioVie Insider Transactions Generation Bio Insider Transactions Vaxart Insider Transactions Context Therapeutics Insider Transactions Galectin Therapeutics Insider Transactions Actuate Therapeutics Insider Transactions Coherus BioSciences Insider Transactions Seres Therapeutics Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: This Is the Top Large-Cap Stock Insiders Are BuyingMatador Resources Insiders Keep Buying Its Stock, Should You?Top 3 Small-Cap Stocks Insiders Are Buying Right Now3 Small Cap Stocks That Insiders Are BuyingMGM Insiders Bet Big on Its Undervalued Stock This page (NASDAQ:ATRA) was last updated on 9/22/2024 by MarketBeat.com Staff From Our PartnersMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored[SHOCKING] Crypto Document Leak…A shocking leak has revealed Japanese electronics giant Sony is now starting its own blockchain. This move ...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredJeff Bezos Just Humiliated Elon MuskThe Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next...InvestorPlace | Sponsored625,000% GainThe recent crypto correction has shaken many investors, causing panic and uncertainty. But while others are fr...Crypto Swap Profits | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Atara Biotherapeutics, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Atara Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.